Multiple Sclerosis and Stem cell therapy
A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells
... Abstract: Multiple sclerosis (MS), a complex disorder of the central nervous system (CNS), is characterized with axonal loss underlying long-term progressive ...embryonic stem cell (hESC) ...
11
Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy
... relapsing-remitting multiple sclerosis Table 3 Patient wise number of cases who scored differ- ently later by at least one grade of RNFS score at ...
6
Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis
... pluripotent stem cells; ISCT: International Society for Cellular Therapy; IV: Intravenous; MAO-B: Monoamine oxidase B; MCP-1: Monocyte chemoattractant protein 1; MHC-II: Major histocompatibility complex ...
22
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
... 8). Cell factories GMP-approved by national authorities expand the BM-derived MSC up to 1– 2 × 10 6 /kg of subject body weight and, after the appropriate quality checks, freeze one IV bag of MSC in infusion medium ...
13
Longitudinal change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic stem cell transplant in multiple sclerosis
... Atrophy has also been noted by other research groups [8–10] and various explanations have been postulated to explain the volume loss including: a selection bias for patients with aggressive disease and potentially faster ...
7
Assessment of bone marrow derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
... BM stem cell sub-populations are in this way in- cluded, and several may be ...haematopoetic stem cells also have repara- tive potential [34, 35], as do CD133-positive stem cells [36, 37]; ...
8
Alemtuzumab: A Place in Therapy for Treatment of Multiple Sclerosis
... While the half-life of a drug varies with concentration and time in nonlinear kinetics (i.e. elimination slows with subsequent doses), the elimination of alemtuzumab after repeated doses is clearly prolonged. A half-life ...
13
T cell repertoire following autologous stem cell transplantation for multiple sclerosis
... T cells in one patient (P21). Such high frequencies of EBV-reactive sequences were not observed in a recent study that used next-gener- ation sequencing of two renal transplant recipients (14), although those patients ...
6
Human embryonic stem cell for the treatment of multiple sclerosis: A case report
... Introduction: Multiple sclerosis (MS) is a chronic demyelinating disease with inflammatory ...embryonic stem cells (hESC) have been investigated in animal models which showed the potency to mitigate ...
5
Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing–remitting multiple sclerosis model
... for multiple sclerosis (MS) ...by multiple factors used to induce the model, such as the animal’s sex, the strain genetic background, the antigen used for immunization, and so ...
14
Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis
... Multiple stem and progenitor cell types could have the potential to either directly replace MNs and diseased glia or provide support to slow ...embryonic stem (ES) cells and induced ...
10
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
... suggests that on-treatment MRI monitoring is more sensitive than composite scores for early prediction of nonresponse to IFNB. Lastly, a “dose-effect” with regard to new MRI lesions has also been described, ie, the ...
10
Multiple Sclerosis: A Review of Existing Therapy and Future Prospects
... T cell vaccination: Innoculation of attenuated clones of T cells recognizing the inciting autoantigen can specifically prevent the induction of disease in animal models of autoimmune diseases 34,35 ...T ...
8
Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis
... Multiple sclerosis (MS) is an inflammatory, demyeli- nating disorder of the CNS with varied clinical presen- tations that range from clearly defined relapses and remissions (RRMS) to slow accumulation of ...
10
Haematopoietic stem cell transplantation in systemic sclerosis
... haematopoietic stem cell transplantation (HSCT) in systemic sclerosis (SSc) demonstrated long-term survival benefits, induction of clinically meaningful, sustained improvement of forced vital ...
7
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses
... For patients who have been on treatment for many years, a misunderstanding of the chronic nature of MS and the need for continual, long-term therapy or a belief that medication is no longer needed may precipitate ...
7
Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis
... that multiple sclerosis (MS) is a T-cell-mediated disease has been changed and it is now widely accepted that B cells play a part in the pathogenesis of ...[1–3] Multiple roles of B cells have ...
10
Stem Cell Therapy- An Overview
... into multiple cell lineages. Stem cells are found in all of us, from the early stages of human development to the end of ...life. Stem cells are unspecialized cells that develop into the ...
11
Stem Cell Therapy: An Overview
... in stem cell therapy has been ...of stem cell therapy has been ...of stem cell therapy for disease that are currently difficult to treat or incurable such as ...
11
“STEM CELL THERAPY” A REVIEW
... biology. Stem cells have been successfully isolated from variety of human ...that stem cells are used for various life-threatening diseases that have so far defeated modern medical ...on stem cells ...
14